Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial.
about
The Renin-Angiotensin-aldosterone system in vascular inflammation and remodelingAngiotensin II receptors and drug discovery in cardiovascular disease.Increased plasma chymase concentration and mast cell chymase expression in venous neointimal lesions of patients with CKD and ESRDIn stent restenosis: bane of the stent era.Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapyImpact of Mast Cell Chymase on Renal Disease Progression.Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.Renin-angiotensin system inhibitors in patients with coronary artery disease who have undergone percutaneous coronary intervention.Influence of valsartan-eluting stent on neointima formation.Initial reduction of oxidative stress by angiotensin receptor blocker contributes long term outcomes after percutaneous coronary interventionEffects of angiotensin receptor blockers on neointimal characteristics in angina patients requiring stent implantation: optical coherence tomography analysis.
P2860
Q21284671-1BA339DC-A379-40FF-94F3-6FA149E84FCAQ34496676-5E0F5632-25A9-4B0C-8153-B4A9F6228A92Q35539717-D54533EC-7F5C-4FC7-8FE3-749E1AB73DB0Q35769824-9FA0BD0F-8FBF-4CA9-AA40-4F589B77E655Q36013124-23DED401-9E85-489C-8C00-06B14C7AEB16Q36682426-F08E9F1B-F18C-4AAF-AFB0-3FB94C1D49BBQ37511128-32F32E57-A2D7-4A85-A449-7D540FF935EDQ38835716-1C6BBC9D-2D40-4ED3-8CEE-5B522EB4A87DQ41225645-3940EC20-E400-4470-ACCE-64D9C3433AF4Q42028373-393AA17C-AC5D-4EDE-84B0-39B09CE0DC31Q47160670-525325B3-C6BB-41F4-94E0-5E6AEC4613DF
P2860
Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Valsartan for prevention of re ...... lesions: the VAL-PREST trial.
@ast
Valsartan for prevention of re ...... lesions: the VAL-PREST trial.
@en
type
label
Valsartan for prevention of re ...... lesions: the VAL-PREST trial.
@ast
Valsartan for prevention of re ...... lesions: the VAL-PREST trial.
@en
prefLabel
Valsartan for prevention of re ...... lesions: the VAL-PREST trial.
@ast
Valsartan for prevention of re ...... lesions: the VAL-PREST trial.
@en
P2093
P1476
Valsartan for prevention of re ...... C lesions: the VAL-PREST trial
@en
P2093
P577
2001-02-01T00:00:00Z